Arcutis Biotherapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Arcutis Biotherapeutics Inc
TickerARQT
CIK #0001787306
CUSIP03969K108
SectorLife Sciences - Pharmaceutical Preparations
Address2945 Townsgate Road Suite 110, Westlake Village, CA 91361
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Arcutis Biotherapeutics Inc 2019-10-22 94.5 M Exemption: 506(b) · Remaining: $33 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001787306] 10-K
[0001787306] 10-Q
[0001787306] 3
[0001787306] 4
[0001787306] 5
[0001787306] 8-K
[0001787306] D
[0001787306] SC 13D
[0001787306] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Arcutis Biotherapeutics Inc [2026-05-12] 0.0
Vanguard Group Inc Arcutis Biotherapeutics Inc [2024-02-13] 5.19
Rubric Capital Management LP Arcutis Biotherapeutics Inc [2024-02-12] 7.04
Morgan Stanley Arcutis Biotherapeutics Inc [2024-02-12] 6.5
Jennison Associates LLC Arcutis Biotherapeutics Inc [2024-02-08] 9.6
Point72 Asset Management LP Arcutis Biotherapeutics Inc [2024-01-31] 5.1
BlackRock Inc Arcutis Biotherapeutics Inc [2024-01-29] 6.3
Polar Capital Holdings PLC Arcutis Biotherapeutics Inc [2023-11-16] 7.56
Prudential Financial Inc Arcutis Biotherapeutics Inc [2023-11-09] 10.25
Suvretta Capital Management LLC Arcutis Biotherapeutics Inc [2023-10-30] 0.99
State Street Corp Arcutis Biotherapeutics Inc [2023-02-08] 6.04
Point72 Asset Management LP Arcutis Biotherapeutics Inc [2021-12-15] 5.0
BlackRock Inc Arcutis Biotherapeutics Inc [2021-02-02] 6.6
FMR LLC Arcutis Biotherapeutics Inc [2020-02-10] 0.0
OrbiMed Advisors LLC Arcutis Biotherapeutics Inc [2020-02-10] 10.7
Frazier Life Sciences VIII LP Arcutis Biotherapeutics Inc [2020-02-07] 27.7
Bain Capital Life Sciences Fund LP Arcutis Biotherapeutics Inc [2020-02-07] 0.5
Form 3/4/5 Filer 2011 - 2026
Welgus Howard G
Arcutis Biotherapeutics Inc
Lin Sue-Jean
Heron Patrick J
Leonard Keith R
Curran Terrie
Munshi Amit
Gilbert Halley E
Krishnamohan Neha
Vairavan Latha
Burnett Patrick
Watanabe Todd
Matsuda Masaru
Edwards Larry Todd
Chaudhuri Bhaskar
Topper David Joseph
Moore Matthew Richard
Smither John W
FHM Life Sciences VIII LLC
Topper James N
FHM Life Sciences VIII LP
Frazier Life Sciences VIII LP
Burrows Scott L
Turney Patricia A
Osborne David W
Lock Kenneth A
OrbiMed Advisors LLC
OrbiMed Capital LLC
OrbiMed Capital GP VII LLC
Turner Joseph L
Sun Ricky
Silverstein Jonathan
Estes Daniel
Bain Capital Life Sciences Fund LP
Schwartz Jeffrey Lawrence
BCIP Life Sciences Associates LP
Koppel Adam
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Investors LLC
Asam Alexander
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Leonard Keith R
Common Stock
2026-03-02 Sell 39,272 $25.39 997,116
Matsuda Masaru
Common Stock
2026-03-02 Sell 6,553 $25.16 164,873
Burnett Patrick
Common Stock
2026-03-02 Sell 6,106 $25.16 153,627
Burnett Patrick
Common Stock
2026-03-02 Sell 181 $25.91 4,690
Edwards Larry Todd
Common Stock
2026-03-02 Sell 103 $25.91 2,669
Watanabe Todd
Common Stock
2026-03-02 Sell 1,068 $25.91 27,672
Leonard Keith R
Common Stock
2026-03-02 Option exercise 12,220 $7.51 91,772
Vairavan Latha
Common Stock
2026-03-02 Sell 2,772 $25.16 69,744
Leonard Keith R
Stock Option (right to buy) · derivative
2026-03-02 Option exercise 27,052 $0.00
Leonard Keith R
Common Stock
2026-03-02 Option exercise 27,052 $8.63 233,459
Vairavan Latha
Common Stock
2026-03-02 Sell 81 $25.91 2,099
Leonard Keith R
Stock Option (right to buy) · derivative
2026-03-02 Option exercise 12,220 $0.00
Matsuda Masaru
Common Stock
2026-03-02 Sell 1,987 $25.70 51,066
Welgus Howard G
Common Stock
2026-03-02 Sell 10,000 $25.65 256,500
Edwards Larry Todd
Common Stock
2026-03-02 Sell 3,584 $25.16 90,173
Watanabe Todd
Common Stock
2026-03-02 Sell 36,281 $25.16 912,830
Matsuda Masaru
Common Stock
2026-03-02 Sell 193 $25.91 5,001
Watanabe Todd
Stock Option (right to buy) · derivative
2026-02-27 Grant 266,000 $0.00
Vairavan Latha
Common Stock
2026-02-27 Grant 27,000 $0.00
Matsuda Masaru
Common Stock
2026-02-27 Grant 37,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 269 131,538,182
2025-12-31 283 127,218,037
2025-09-30 240 124,867,586
2025-06-30 230 125,914,800
2025-03-31 243 123,888,207
2024-12-31 211 128,905,753
2024-09-30 190 128,220,919
2024-06-30 189 125,767,574
2024-03-31 169 134,388,735
2023-12-31 135 105,937,959
2023-09-30 138 65,707,684
2023-06-30 142 70,637,611
Form 13F Holdings
Firm Period DFND Voting Shares
Perpetual Ltd [2026-06-30] DFND 1,109,657 1,109,657
Peregrine Capital Management LLC [2026-06-30] SOLE 108,434 291,447
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 75,572 75,572
PSP Research LLC [2026-06-30] SOLE 0 19,700
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 450 12,678
Ballentine Partners LLC [2026-06-30] SOLE 0 9,127
Ballentine Partners LLC [2026-06-30] OTR 0 1,103
Gamma Investing LLC [2026-06-30] DFND 1,014 1,014
Farther Finance Advisors LLC [2026-06-30] SOLE 0 746
1620 Investment Advisors Inc [2026-06-30] SOLE 711 711
IFP Advisors LLC [2026-06-30] SOLE 183 183
Versant Capital Management Inc [2026-06-30] SOLE 80 80
True Wealth Design LLC [2026-06-30] SOLE 0 80
Owl Creek Wealth Partners LLC [2026-06-30] SOLE 0 55
Fortitude Family Office LLC [2026-06-30] SOLE 48 48
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 46
Handelsbanken Fonder AB [2026-06-30] SOLE 0 43
Hughes Financial Services LLC [2026-06-30] SOLE 2 2
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com